Cargando…
Stability of extemporaneously compounded amiloride nasal spray
Anxiety disorders (AD) are the most common mental conditions affecting an estimated 40 million adults in the United States. Amiloride, a diuretic agent, has shown efficacy in reducing anxious responses in preclinical models by inhibiting the acid-sensing ion channels (ASIC). By delivering amiloride...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351165/ https://www.ncbi.nlm.nih.gov/pubmed/32649677 http://dx.doi.org/10.1371/journal.pone.0232435 |
_version_ | 1783557397396062208 |
---|---|
author | Yellepeddi, Venkata Sayre, Casey Burrows, Anna Watt, Kevin Davies, Simon Strauss, John Battaglia, Marco |
author_facet | Yellepeddi, Venkata Sayre, Casey Burrows, Anna Watt, Kevin Davies, Simon Strauss, John Battaglia, Marco |
author_sort | Yellepeddi, Venkata |
collection | PubMed |
description | Anxiety disorders (AD) are the most common mental conditions affecting an estimated 40 million adults in the United States. Amiloride, a diuretic agent, has shown efficacy in reducing anxious responses in preclinical models by inhibiting the acid-sensing ion channels (ASIC). By delivering amiloride via nasal route, rapid onset of action can be achieved due to direct “nose-to-brain” access. Therefore, this study reports the formulation, physical, chemical, and microbiological stability of an extemporaneously prepared amiloride 2 mg/mL nasal spray. The amiloride nasal spray was prepared by adding 100 mg of amiloride hydrochloride to 50 mL of sterile water for injection in a sterile reagent bottle. A stability-indicating high-performance liquid chromatography (HPLC) method was developed and validated. Forced-degradation studies were performed to confirm the ability of the HPLC method to identify the degradation products from amiloride distinctively. The physical stability of the amiloride nasal spray was assessed by pH, clarity, and viscosity assessments. For chemical stability studies, samples of nasal sprays stored at room temperature were collected at time-points 0, 3 hr., 24 hr., and 7 days and were assayed in triplicate using the stability-indicating HPLC method. Microbiological stability of the nasal spray solution was evaluated for up to 7 days based on the sterility test outlined in United States Pharmacopoeia (USP) chapter 71. The stability-indicating HPLC method identified the degradation products of amiloride without interference from amiloride. All tested solutions retained over 90% of the initial amiloride concentration for the 7-day study period. There were no changes in color, pH, and viscosity in any sample. The nasal spray solutions were sterile for up to 7 days in all samples tested. An extemporaneously prepared nasal spray solution of amiloride hydrochloride (2 mg/mL) was physically, chemically, and microbiologically stable for 7 days when stored at room temperature. |
format | Online Article Text |
id | pubmed-7351165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-73511652020-07-20 Stability of extemporaneously compounded amiloride nasal spray Yellepeddi, Venkata Sayre, Casey Burrows, Anna Watt, Kevin Davies, Simon Strauss, John Battaglia, Marco PLoS One Research Article Anxiety disorders (AD) are the most common mental conditions affecting an estimated 40 million adults in the United States. Amiloride, a diuretic agent, has shown efficacy in reducing anxious responses in preclinical models by inhibiting the acid-sensing ion channels (ASIC). By delivering amiloride via nasal route, rapid onset of action can be achieved due to direct “nose-to-brain” access. Therefore, this study reports the formulation, physical, chemical, and microbiological stability of an extemporaneously prepared amiloride 2 mg/mL nasal spray. The amiloride nasal spray was prepared by adding 100 mg of amiloride hydrochloride to 50 mL of sterile water for injection in a sterile reagent bottle. A stability-indicating high-performance liquid chromatography (HPLC) method was developed and validated. Forced-degradation studies were performed to confirm the ability of the HPLC method to identify the degradation products from amiloride distinctively. The physical stability of the amiloride nasal spray was assessed by pH, clarity, and viscosity assessments. For chemical stability studies, samples of nasal sprays stored at room temperature were collected at time-points 0, 3 hr., 24 hr., and 7 days and were assayed in triplicate using the stability-indicating HPLC method. Microbiological stability of the nasal spray solution was evaluated for up to 7 days based on the sterility test outlined in United States Pharmacopoeia (USP) chapter 71. The stability-indicating HPLC method identified the degradation products of amiloride without interference from amiloride. All tested solutions retained over 90% of the initial amiloride concentration for the 7-day study period. There were no changes in color, pH, and viscosity in any sample. The nasal spray solutions were sterile for up to 7 days in all samples tested. An extemporaneously prepared nasal spray solution of amiloride hydrochloride (2 mg/mL) was physically, chemically, and microbiologically stable for 7 days when stored at room temperature. Public Library of Science 2020-07-10 /pmc/articles/PMC7351165/ /pubmed/32649677 http://dx.doi.org/10.1371/journal.pone.0232435 Text en © 2020 Yellepeddi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Yellepeddi, Venkata Sayre, Casey Burrows, Anna Watt, Kevin Davies, Simon Strauss, John Battaglia, Marco Stability of extemporaneously compounded amiloride nasal spray |
title | Stability of extemporaneously compounded amiloride nasal spray |
title_full | Stability of extemporaneously compounded amiloride nasal spray |
title_fullStr | Stability of extemporaneously compounded amiloride nasal spray |
title_full_unstemmed | Stability of extemporaneously compounded amiloride nasal spray |
title_short | Stability of extemporaneously compounded amiloride nasal spray |
title_sort | stability of extemporaneously compounded amiloride nasal spray |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351165/ https://www.ncbi.nlm.nih.gov/pubmed/32649677 http://dx.doi.org/10.1371/journal.pone.0232435 |
work_keys_str_mv | AT yellepeddivenkata stabilityofextemporaneouslycompoundedamiloridenasalspray AT sayrecasey stabilityofextemporaneouslycompoundedamiloridenasalspray AT burrowsanna stabilityofextemporaneouslycompoundedamiloridenasalspray AT wattkevin stabilityofextemporaneouslycompoundedamiloridenasalspray AT daviessimon stabilityofextemporaneouslycompoundedamiloridenasalspray AT straussjohn stabilityofextemporaneouslycompoundedamiloridenasalspray AT battagliamarco stabilityofextemporaneouslycompoundedamiloridenasalspray |